Zurueck zur Suche

Reporte zur Charge U014656

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MO 6 TX 4 MD 2 IN 1 CA 1 NJ 1 NY 1 SC 1

VAERS 2360924

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

schwer
Staat
IN
Alter
1,4
Geschlecht
F
Eingang
07.07.2022
Impfdatum
13.06.2022
Beginn
22.06.2022
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pyrexia Seizure

Symptomtext

Patient received MMR vaccine on June 13 2022 . Mother Called and left a voicemail on June 23 2022, stating that daughter had developed a fever of 102 F in the morning of June 22, 2022 and that later in the evening around 7:00 pm daughter developed a seizure. This Nurse called and left voicemail to call back to discuss adverse event, and instructed mom to give medication to keep fever down. On June 30th mom left a voicemail stating, Patient had another seizure on Thursday, June 23, 2022 as well. Mother stated that she had went to PCP Friday June 24th and was instructed to give Tylenol and Motrin to keep fever down and prevent any more fibril seizures from occurring. per mother child is doing well and back to normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
no medication or supplements taken prior to vaccination
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2585071

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

mild
Staat
TX
Alter
37,0
Geschlecht
M
Eingang
21.02.2023
Impfdatum
23.01.2023
Beginn
24.01.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site inflammation Injection site swelling

Symptomtext

PATIENT COMPLAINED OF SWELLING AND INFLAMMATION IN THE ELBOW OF LEFT ARM EVEN AFTER ALMOST ONE MONTH, BEGINNING WITH THE FIRST DAY AFTER INJECTION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site inflammation
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2627028

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
CA
Alter
43,0
Geschlecht
F
Eingang
04.05.2023
Impfdatum
04.05.2023
Beginn
04.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered at inappropriate site Underdose

Symptomtext

Incorrectly administered 0.1 ml of MMR vaccine IM on the Left Deltoid. Stopped immediately once known that wrong site was used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered at inappropriate site
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2497053

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
03.11.2022
Impfdatum
13.10.2022
Beginn
13.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE information provided; MMR II underwent multiple temperature excursions was administered to a patient; This spontaneous report was received from a pharmacist and referring to an unspecified patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not provided. On 13-OCT-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (lot #U014656 with an expiration date on 07-MAY-2023), administered for prophylaxis (strength, anatomical location and route of administration were not provided). The doses of vaccine underwent multiple temperature excursions of 9.13 ?C (Celsius degrees) for 1 hour; and -8.45 ?C for 37 hours and 15 minutes (incorrect product storage). No additional adverse event information was provided. No previous temperature excursions were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2467995

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
04.10.2022
Impfdatum
30.08.2022
Beginn
30.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's and no PQC's were reported; A physician stated that an improperly stored dose of MMR II pursuant to a temperature excursion was administered to a patient. ?; This spontaneous report was received from a physician referring to a patient of unreported age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-AUG-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) rHA, U014656 (also reported as: W014656), expiration date: 07-MAY-2023, to prevent measles, mumps and rubella infection (dose, route and site of administration were not reported). The administered dose of the vaccine experienced a temperature excursion of 13.8F and 51F for 25 hours and 100 hours respectively (product storage error). The vaccines had not had any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved. Lot Number W014656 is NOT valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), and does not match any company product.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2449420

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MD
Alter
15,0
Geschlecht
M
Eingang
17.09.2022
Impfdatum
07.09.2022
Beginn
07.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional AE; patient was inadvertently administered VARIVAX and MMRII via intramuscular route as opposed to recommended subcutaneous route; This spontaneous report was received from physician and refers to a 15-year-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 07-SEP-2022, the patient was vaccinated with dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #T032318, expiration date: 22-SEP-2022, administered intramuscularly for prophylaxis (strength was not provided); and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #U014656, expiration date: 07-MAY-2023, administered intramuscularly for prophylaxis (strength was not provided) (incorrect route of product administration). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2434643

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MD
Alter
15,0
Geschlecht
M
Eingang
08.09.2022
Impfdatum
07.09.2022
Beginn
07.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration

Symptomtext

Vaccinations prescribed to be given sq were given IM . Both MMR and Varicella. MD notified and ordered for monitoring for fever and arm soreness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
sprained ankle
Vorgeschichte
Obesity
Andere Medikamente
Ibuprofen, Zyprexia
Allergien
None
Vorherige Impfungen
-

VAERS 2341850

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
29.06.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
UN / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

11 YEAR PATIENT GIVEN MMR WHEN MCV WAS ORDERED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2321443

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MO
Alter
-
Geschlecht
M
Eingang
16.06.2022
Impfdatum
09.05.2022
Beginn
09.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. Excursion on 03-MAY-2022. The vaccine had been administered since the excursion occurred.; This spontaneous report was received from a nurse referring to a 13 month old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The reporter reported two temperature excursions on multiple refrigerated vaccines.She said it was very likely all vaccines had been administered since the excursions occurred. As she was looking through her data, she estimated there would be around 40 patients who have been administered vaccines alone and many others who had received the other vaccine types. After all, it was confirmed that on 03-MAY-2022, the vaccine measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # U014656 with expiration date on 07-MAY-2023, had a temperature excursion at 47.3F for 5 minutes. and on 09-MAY-2022, the patient was vaccinated with tat vaccine for prophylaxis (dose and route were not reported). No additional adverse event was reported and no product quality complaint was identified. This is one of multiple reports from the same reporter.; Sender's Comments: US-009507513-2206USA001586: US-009507513-2206USA001587: US-009507513-2206USA001588: US-009507513-2206USA001590: US-009507513-2206USA001591: US-009507513-2206USA001592: US-009507513-2206USA001594: US-009507513-2206USA001600: US-009507513-2206USA001585: US-009507513-2206USA001584: US-009507513-2206USA001583: US-009507513-2206USA001589: US-009507513-2204USA002052: US-009507513-2204USA001998: US-009507513-2204USA001952: US-009507513-2204USA001865: US-009507513-2206USA001582: US-009507513-2206USA001593: 2US-009507513-206USA001595: US-009507513-2206USA001596: US-009507513-2206USA001597: US-009507513-2206USA001598: US-009507513-2206USA001599: 2US-009507513-206USA001600:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2314895

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MO
Alter
2,0
Geschlecht
F
Eingang
10.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022. She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, a 2-year-old female patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 03-MAY-2022, the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # U014656 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes; additionally on 26-MAY-2022 experienced an additional temperature excursion of 35.2 F for 56 seconds. If a digital data logger was involved was not reported (product storage error) (product storage error). Consequently, on unknown dates 31-MAY-2022, the patients was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot number reported as U014656 confirmed as valid, expiration date reported and stablished as 07-MAY-2023) administered as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001103:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313624

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MO
Alter
1,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022. She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, concerning a 12-months-old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 03-MAY-2022, the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # U014656 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes, if a digital data logger was involved was not reported (product storage error). Consequently, on 24-MAY-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot number reported as U014656 confirmed as valid, expiration date reported and stablished as 07-MAY-2023) administered as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001103:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313623

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MO
Alter
1,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022. She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, concerning a 12-months-old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 03-MAY-2022, the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # U014656 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes, if a digital data logger was involved was not reported (product storage error). Consequently, on 24-MAY-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot number reported as U014656 confirmed as valid, expiration date reported and stablished as 07-MAY-2023) administered as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001103:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313621

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MO
Alter
1,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022. She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, concerning a 12-months-old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 03-MAY-2022, the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # U014656 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes, if a digital data logger was involved was not reported (product storage error). Consequently, on 23-MAY-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot number reported as U014656 confirmed as valid, expiration date reported and stablished as 07-MAY-2023) administered as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001103:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2312432

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
MO
Alter
1,1
Geschlecht
F
Eingang
08.06.2022
Impfdatum
09.05.2022
Beginn
09.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022. She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, concerning a 13-months-old female patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 03-MAY-2022, the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # U014656 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes, if a digital data logger was involved was not reported (product storage error). Consequently, on 09-MAY-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot number reported as U014656 confirmed as valid, expiration date reported and stablished as 07-MAY-2023) administered as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event).; Sender's Comments: US-009507513-2206USA001582: US-009507513-2206USA001583: US-009507513-2206USA001584: US-009507513-2206USA001585: US-009507513-2206USA001586: US-009507513-2206USA001587: US-009507513-2206USA001588: US-009507513-2206USA001589: US-009507513-2206USA001590: US-009507513-2206USA001591: US-009507513-2206USA001592: US-009507513-2206USA001593: US-009507513-2206USA001594: US-009507513-2206USA001595: US-009507513-2206USA001596: US-009507513-2206USA001597: US-009507513-2206USA001598: US-009507513-2206USA001599: US-009507513-2206USA001600: US-009507513-2204USA001865: US-009507513-2204USA001998: US-009507513-2204USA002052: US-009507513-2204USA001952: US-009507513-2206USA001103:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2308485

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
SC
Alter
4,0
Geschlecht
M
Eingang
03.06.2022
Impfdatum
27.05.2022
Beginn
27.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

The medication was expired.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None, Pt did not experience any adverse effects from the medication.
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2283429

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
TX
Alter
7,0
Geschlecht
M
Eingang
18.05.2022
Impfdatum
11.05.2022
Beginn
11.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient was given these immunizations on 05/11/2022 but he had already received 4 yr old vaccines. No symptoms were presented.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2261729

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U014656

gering
Staat
TX
Alter
17,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

N/A.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-